Product NDC: | 0374-5070 |
Proprietary Name: | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
Non Proprietary Name: | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
Active Ingredient(s): | 75 mg/5mL & nbsp; CLINDAMYCIN PALMITATE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | GRANULE, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0374-5070 |
Labeler Name: | Lyne Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA201821 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120911 |
Package NDC: | 0374-5070-01 |
Package Description: | 100 mL in 1 BOTTLE (0374-5070-01) |
NDC Code | 0374-5070-01 |
Proprietary Name | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
Package Description | 100 mL in 1 BOTTLE (0374-5070-01) |
Product NDC | 0374-5070 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
Dosage Form Name | GRANULE, FOR SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20120911 |
Marketing Category Name | ANDA |
Labeler Name | Lyne Laboratories, Inc. |
Substance Name | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
Strength Number | 75 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |